Amferia and Orkla Wound Care have inked an exclusive three-year licence and purchase agreement that covers the Nordic region, Germany, Spain, and Portugal, with the option for an extension. Through the joint venture with Orkla Wound Care, Amferia's technology will be able to reach the larger European veterinary market, where wound care and infection prevention are critical. This will be done through Orkla's premier brand, Snögg Animal Care.
Researchers and engineers at RMIT University in Australia have developed smart wound dressings with built-in sensors to monitor the healing process and reduce inflammation.
If an infection begins, the fluorescent nanosensors glow under ultraviolet (UV) light.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 2856
Published Date: Jan 18, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are a surge in road accidents, rising hospital acquired infection, and growth in technological advancement in antimicrobial wound dressings.
The market size of antimicrobial wound dressings is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.
The major players in the market are Amferia AB, 3M, Smith & Nephew, Cardinal Health, and others.
The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.